COVID vaccine could take "life off of pause" for some kids
Millions of vaccine doses have already been packaged and shipped around the country and are ready for pediatricians and pharmacies to use immediately.
Pfizer
COVID vaccine for children ages 5-11
The Centers for Disease Control and Prevention is on the verge of reccomending the Pfizer COVID-19 vaccination for children between the ages of 5 and 11. Dr. Julie Morita, executive vice president at the Robert Wood Johnson Foundation, joined CBSN to discuss the vaccination and what this means for parents.
CDC panel recommends Pfizer vaccine for kids
Centers for Disease Control and Prevention advisers voted to recommend Pfizer's COVID-19 vaccine for children as young as 5. Meg Oliver shares more.
Doctor on COVID vaccine for young kids
A CDC advisory panel is meeting today to consider recommending Pfizer's COVID-19 vaccine for children ages 5 to 11. Dr. Dyan Hes, founder of Gramercy Pediatrics, joins CBSN to discuss the latest coronavirus headlines.
Innovative program helps kids overcome their fear of needles
An estimated 63% of children are afraid of needles but technology is helping families reduce fear and anxiety.
COVID-19 vaccine for kids expected soon
The CDC is expected to authorize use of a reduced-dose Pfizer vaccine for kids ages 5 to 11 this week. Dr. Mark Kline, physician-in-chief at Children's Hospital New Orleans, joins CBSN to discuss what parents need to know about protecting their children against the coronavirus.
Pfizer vaccine nears approval for children and teens
Millions of American parents are watching as the Pfizer vaccine nears approval for children and teens. Mark Strassmann reports.
FDA authorizes Pfizer's COVID shot for kids
The Pfizer children's vaccine is about a third of the adult dose, but a clinical trial found it was nearly 91 percent effective at preventing COVID-19. If it gets final CDC approval next week, some 28 million children will be eligible for shots. Michael George has the latest.
FDA authorizes Pfizer vaccine for kids 5 to 11
The FDA authorized Pfizer's COVID vaccine for children ages 5 to 11, saying it was nearly 91% effective against symptomatic disease. Meg Oliver has the latest.
Doctor on new boosters and vaccinating kids
A fourth COVID-19 vaccine shot will soon be available for some immunocompromised adults across the country. Meanwhile, the Food and Drug Administration could authorize Pfizer's vaccine for emergency use in children ages 5-11 in the coming days. Dr. Hilary Fairbrother, an emergency medicine physician, joined CBSN to discuss.
COVID vaccine for kids is one step closer
An FDA advisory panel is endorsing a reduced-dose version of Pfizer's COVID-19 vaccine for kids aged 5 to 11. If the FDA and CDC sign off, shots for kids could be available by late next week. CBS News' Debra Alfarone reports, and then Dr. Stanley Perlman, a member of the FDA panel, joins CBSN's Tanya Rivero to discuss to vaccine and what it means for children and parents.
CDC suggests 4th shot for immunocompromised
The Centers for Disease Control and Prevention has updated its guidance for people with compromised immune systems, saying they can now get a fourth Pfizer or Moderna COVID-19 shot.
FDA panel endorses Pfizer COVID vaccine for kids
Pfizer's COVID-19 vaccine for children is one step closer to being approved after an FDA advisory committee voted unanimously to recommend lower doses of the shot for kids aged 5 to 11. CBS News correspondent Janet Shamlian reports on the panel's decision. Then, Dr. Ben Weston, an associate professor in the department of emergency medicine at the Medical College of Wisconsin, joins CBSN's Elaine Quijano to discuss the latest.
Kids could get Pfizer COVID vaccine soon
A Food and Drug Administration advisory committee is meeting Tuesday to consider endorsing Pfizer's COVID-19 vaccine for children ages 5 to 11. Dr. Mark Kline, chief physician at New Orleans Children's Hospital, spoke with CBSN's Tanya Rivero about what's next.
FDA panel considers Pfizer vaccine for kids
An FDA advisory panel is meeting today to consider if millions of younger children, ages 5 to 11, should be eligible for Pfizer's COVID-19 vaccine. CBS News' Laura Podesta joins CBSN AM with the latest.
Pediatrician on COVID vaccine for young kids
FDA advisers are meeting to consider recommending the Pfizer COVID-19 vaccine for kids aged 5 to 11. Meanwhile, Moderna says its data shows a strong immune response in young children from its shot. Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss these latest developments.
Moderna says vaccine is safe for kids 6 to 11
On Tuesday, an FDA advisory committee is meeting on whether to green light Pfizer's lower-dose vaccine for kids 5 to 11 years old. And there's the possibility of another vaccine for young children. Meg Oliver has the details.
Moderna says COVID vaccine is effective in kids
Millions of children under the age of 12 could be eligible for a COVID-19 vaccine in just a matter of weeks. Moderna says a low dosage of its coronavirus vaccine is safe and appears effective in kids age 6 to 11. Meanwhile, an FDA committee will meet Tuesday to discuss whether to approve Pfizer's vaccine for children. CBS News correspondent Meg Oliver has the latest. Then, Dr. Shikha Jain, assistant professor of medicine at the University of Illinois Chicago, joins CBSN's Elaine Quijano to discuss.
Pfizer says vaccine is 90.7% effective in kids
More than 70 million Americans are eligible for COVID-19 booster shots. The number of Americans getting boosters each day is now more than double the number getting their first shots. And there's important news tonight on Pfizer's dose for young children. Meg Oliver reports.
CDC backs J&J and Moderna vaccine boosters
A CDC panel has voted in favor of the Johnson and Johnson and Moderna COVID-19 vaccine booster shots. Pending approval from the agency's director, millions of people could soon line up for an additional dose. CBS News' Meg Oliver breaks down the decision. Then, critical care physician Dr. Lakshmana Swamy joins CBSN's Lana Zak with his analysis.
Pfizer says its booster shot restores full COVID-19 protection
Pfizer and BioNTech said their latest trial shows boosters could help bring a "return to normalcy."
Biden rolls out COVID vaccine plan for kids
As Americans await FDA approval for two COVID-19 booster shot options, President Biden is unveiling his plan to get kids ages 5 to 11 vaccinated. Dr. Taison Bell, medical ICU director at the University of Virginia, joins CBSN's Tanya Rivero to break down the news.
Pfizer vaccine 93% effective against hospitalization for kids
A new study shows Pfizer's COVID-19 vaccine to be even more effective against hospitalization for kids than it is for adults. For kids, the vaccine is 93% effective against hospitalization, compared to 88% for adults who are not immunocompromised. Lilia Luciano reports on the study and more.
COVID booster shots and immunocompromised
The Food and Drug Administration is reportedly close to approving "mixing and matching" COVID booster shots. CBS News' Skyler Henry reports that people could soon get a different shot than the one they originally received and Dr. Theodore Strange, chair of medicine at Staten Island University Hospital in New York City, joined CBSN to discuss what this means, especially for immunocompromised Americans.
Report: FDA may OK mix-and-match boosters
The Food and Drug Administration is reportedly set to allow a mix-and-match approach for COVID-19 vaccine booster shots. According to The New York Times, the agency could announce its decision Wednesday, when it's expected to authorize the Moderna and Johnson & Johnson boosters. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
CBS News poll finds few feel shutdown is worth it
Americans are concerned about effect of shutdown on economy, amid unease about jobs and inflation.
Johnson, Schumer accuse each other of not being serious in shutdown negotiations
Congressional leaders traded blame for the government shutdown on Sunday as the stalemate over how to reopen the government stretched into another week without progress on negotiations.
As justices confront harassment, death threats, Barrett says "I'm not afraid"
In an interview with CBS News, Justice Amy Coney Barrett said of the Supreme Court's emergency orders in the Trump cases, "This isn't the final decision."
Tropical Storm Priscilla forms in the Pacific. Maps show its path.
Tropical Storm Priscilla was strengthening Sunday in the Pacific Ocean, off the southwestern coast of Mexico.
Rubio says release of Gaza hostages is "most emergent and immediate phase" of Trump plan
"Let's discuss through the mediators the logistics and the mechanics behind how that happens, and that has to happen very quickly. That cannot drag on," Secretary of State Marco Rubio said.
AI in the military: Testing a new kind of air force
Preparing for the threats of tomorrow, the U.S. Air Force is testing drones piloted by artificial intelligence alongside aircraft flown by humans – and is teaching AI how to fight, a potential revolution in warfare.
Pritzker: Trump administration intends to federalize 300 Illinois National Guard
The statement comes amid clashes between protesters and federal agents in Broadview, Illinois, and other reported ICE activity around the city of Chicago.
2 dead, 12 injured in Montgomery, Alabama mass shooting
Rival gunmen started shooting at each other in a crowded downtown nightlife district in Alabama's capital city Saturday night, police said.
Ex-NFL QB Mark Sanchez arrested on battery charges after being hospitalized
Mark Sanchez, who is a Fox Sports analyst, was arrested on multiple misdemeanor charges at an Indianapolis hospital, police said.